BioStem Technologies, Inc.
BSEM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $226,539 | $80,323 | $34,102 | $12,153 |
| - Cash | $22,833 | $239 | $772 | $340 |
| + Debt | $4,501 | $4,774 | $5,209 | $4,831 |
| Enterprise Value | $208,208 | $84,858 | $38,539 | $16,644 |
| Revenue | $301,827 | $16,685 | $6,875 | $4,341 |
| % Growth | 1,708.9% | 142.7% | 58.4% | – |
| Gross Profit | $287,860 | $15,424 | $5,993 | $2,866 |
| % Margin | 95.4% | 92.4% | 87.2% | 66% |
| EBITDA | $31,494 | -$7,554 | -$6,520 | -$602 |
| % Margin | 10.4% | -45.3% | -94.8% | -13.9% |
| Net Income | $31,884 | -$8,483 | -$7,075 | -$1,445 |
| % Margin | 10.6% | -50.8% | -102.9% | -33.3% |
| EPS Diluted | 1.47 | -0.62 | -0.62 | -0.12 |
| % Growth | 337.1% | 0% | -416.7% | – |
| Operating Cash Flow | $24,477 | -$3,499 | -$1,637 | -$109 |
| Capital Expenditures | -$427 | -$105 | -$469 | -$43 |
| Free Cash Flow | $24,050 | -$3,604 | -$2,106 | -$152 |